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Obesity represents a major risk factor for the development of a number of metabolic dis-
orders, including cardiovascular disease and type 2 diabetes. Since the discovery that 
brown and beige fat cells exist in adult humans and contribute to energy expenditure, 
increasing interest has been devoted to the understanding of the molecular switches 
turning on calorie utilization. It has been reported that the ability of thermogenic tissues 
to burn energy declines during aging, possibly contributing to the development of meta-
bolic dysfunction late in life. This review will focus on the recently identified transcriptional 
modulators of brown and beige cells and will discuss the potential impact of some of 
these thermogenic factors on age-associated metabolic disorders.
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iNTRODUCTiON
Obesity arises when the caloric input exceeds energy output. The principal organ that expands in 
response to nutritional overload is white fat, a tissue endowed with the critical evolutionary role to 
conserve and store energy, as triglycerides, to be deployed during periods of nutrients unavailability. 
White adipose depots located in diverse anatomical locations, such as in the visceral cavity and under 
the skin, have been shown to expand differentially in response to nutritional cues, hormonal signals, 
and during the aging process. In antithesis to white, brown fat, mainly present in the interscapular 
area in rodents and rich in mitochondria interspersed among multilocular lipid droplets, is entrusted 
with the function of burning chemical energy to generate the heat required to maintain core body 
temperatures during adverse atmospheric events, such as acute or prolonged exposure to cold (1, 
2). For its thermogenic function, brown fat tissue relies on UCP1, a mitochondrial protein that 
uncouples oxidative phosphorylation from ATP synthesis, generating mitochondrial proton leak 
leading to energy dissipation (3). For a number of years, it had been suspected that an additional 
type of fat cells existed embedded within some of the white depots and thought to be responsible for 
the heterogeneous, mixed histological appearance observed after changes in ambient temperatures 
or in response to certain pharmacological stimuli; such elusive cells have been recently isolated in 
mice and called beige because of their intermediate functional characteristics between white and 
brown adipocytes (4). Beige cells have a smooth muscle-like developmental origin (5), deriving 
from precursors distinct from those known to give rise to white or brown fat, possess specific gene 
signatures, and are contradistinguished by unique markers, such as the developmental factor Tbx1 
(4, 6). In response to cold temperatures or β-adrenergic stimuli, beige cells present in subcutaneous 
white tissue can promptly switch from energy storage functions to programs that initiate calorie 
burning through the induction of a futile cycle that involves creatine metabolism (7), in addition 
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to the activation of`UCP1-dependent thermogenic programs 
characteristic of brown fat cells. Because of the ability of these 
beige cells to mount a rapid thermogenic response, together with 
brown fat cells, they have been considered contributors to the 
overall ability of organisms to expend energy (8, 9).
TRANSCRiPTiONAL MODULATORS OF 
THeRMOGeNeSiS
The functional importance of brown fat for heat generation to 
protect animals from the perils of exposure to low temperatures 
in the wilderness has been recognized for decades and has rep-
resented the focus of studies by morphologists and biochemists 
for a number of years. However, only in the last 15 years, there 
has been an improvement in our understanding of the molecular 
mechanisms that guide the development and govern the func-
tion of thermogenic tissues. Recent radiographic and molecular 
evidence establishing the presence of brown and beige tissues also 
in adult humans (10–14), in addition to neonates and rodents, 
has sparked an interest in the possibility of identifying molecular 
switches to be targeted for the induction of energy consumption 
as anti-obesity intervention (15).
PGC1α
One of the first advances in this field was made in the late 90s in the 
laboratory of Bruce Spiegelman, where Puigserver and colleagues 
performed a yeast two-hybrid screen to identify novel interactors 
of the master regulator of adipocyte differentiation, PPARγ, in 
brown fat tissue (16). This work led to the characterization of the 
peroxisome proliferator-activated receptor gamma coactivator 
1α, PGC1α, as a novel coregulator of UCP1 expression, rapidly 
induced in brown fat upon cold exposure. It has now been recog-
nized that PGC1α can modulate metabolism through its interac-
tion with a number of transcription factors on promoters of genes 
encoding for proteins involved in metabolic functions, such as 
mitochondrial and peroxisomal remodeling and biogenesis, and 
β-oxidation in brown fat (17–19). Analysis of the in vivo require-
ments of PGC1α has demonstrated a direct involvement of PGC1α 
in thermogenesis and in beige fat biology as shown by the blunted 
response to cold challenge of mice with fat-specific deletion of 
PGC1α and by the decreased levels of thermogenic markers, such 
as UCP1, in the inguinal fat pads (iWAT) of Fat-PGC1α KO mice 
(20). In addition to the classic inducers of brown fat function, such 
as β-adrenergic stimuli and CREB signaling, known to regulate 
PGC1α mRNAs, it has been demonstrated that PGC1α protein 
levels can be regulated in an autocrine/paracrine fashion by fac-
tors such as FGF21, prompting PGC1α-dependent browning of 
iWAT (21). Given the role of PGC1α as a critical transcriptional 
coregulator of energy balance, a large emphasis has been placed on 
the identification of the upstream factors and signaling pathways 
that activate PGC1α and on the characterization of PGC1α down-
stream targets to ultimately enhance energy expenditure.
PRDM16
To further understand the mechanisms regulating brown fat 
physiology and to identify the key contributors to brown fat 
identity, a few years after the discovery of PGC1α, the Spiegelman 
laboratory carried out a systematic search for transcriptional 
regulators differentially expressed in brown fat tissue in com-
parison to epididymal white depots. Through this analysis, Seale 
and colleagues identified the zinc finger protein PR domain 
containing 16, PRDM16, as a brown fat selective cofactor able 
to activate brown fat gene programs (22). Mechanistically, it was 
demonstrated that PRDM16 can modulate UCP1 expression 
via its direct interaction with PGC1α and β. Studies of putative 
brown fat depots of WT and PRDM16 global knockout mice at 
embryonic day 17 showed reduced expression of thermogenic 
genes and elevation of muscle-specific genes supporting a role 
for PRDM16 as an early determinant of brown fat lineage and 
as a negative regulator of muscle development (23). Analysis of 
transgenic mice with conditional expression of PRDM16 in white 
fat driven by the promoter of the fatty acid binding protein, aP2, 
demonstrated that PRDM16 is also involved in the development 
of beige adipocytes in subcutaneous fat and that it induces ther-
mogenic genes, such as Ucp1, Cidea, Cox8b, and Elovl3, in these 
cells. The molecular changes induced by in vivo overexpression 
of PRDM16 in fat tissue were associated with increased whole 
body energy expenditure and protection from the weight gain 
induced by high-fat diet, indicating a selective role for PRDM16 
in adaptive thermogenic responses mediated by beige cells (24). 
Conversely, analysis of mice with ablation of PRDM16 selectively 
in adipose tissues demonstrated that the absence of PRDM16 
is associated with a switch in the molecular and morphological 
characteristics of inguinal fat into those of epididymal WAT. Mice 
with fat selective ablation of PRDM16 exposed to high-fat and 
-carbohydrate diet for 16 weeks maintained at room temperature 
developed obesity and insulin resistance (25). Of note, the effects 
of PRDM16 ablation in fat tissues driven by the adiponectin 
promoter appeared to be inguinal fat specific, causing the deple-
tion in beige cells but not altering brown fat tissue functionality. 
Overall these gain- and loss-of-function studies performed both 
in vitro and in vivo have provided evidence for a role of PRDM16 
in the regulation of brown and beige fat tissues maintenance and 
in restricting muscle developmental programs.
PRDM3
Recently, Harms and colleagues in the laboratory of Seale 
demonstrated that PRDM3, a factor closely related to PRDM16, 
plays a role in establishing brown fat identity (26). PRDM3 
induces UCP1 and PGC1α when overexpressed in C2C12 cells. 
PRDM3 levels appear to be highly regulated and are shown to 
decline in brown fat tissue as the mice age, with the highest levels 
observed at embryonic stage 18. These data suggest that PRDM3 
may complement the function of PRDM16 during early devel-
opmental phases. This possibility is supported by the evidence 
that double knockout mice for both PRDM3 and PRDM16 have 
marked decrease in brown fat formation. Recent molecular data 
have demonstrated that, similarly to PRDM16, PRDM3 can 
alter chromatin structure at brown fat gene-specific promoters 
via its interaction with MED1, thereby enhancing target gene 
expression (27). Given that PRDM3 has been reported to play 
broad fundamental functions in heterochromatin maintenance 
(28), future studies may reveal how PRDM3 regulates gene 
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transcription in a depot-selective manner and whether it may rely 
on additional – yet to be identified – tissue-specific interacting 
partners to achieve brown fat tissue effects.
TAF7L
Another important molecular determinant of brown fat was 
recently discovered in the laboratory of Robert Tijan. Zhou and 
colleagues reported that the TATA-binding protein-associated 
factor 7L (TAF7L), previously shown to be a critical regulator of 
white adipose tissue differentiation, also functions as a molecular 
switch between brown fat and muscle lineages (29). Through 
studies involving histological and molecular analysis, Zhou and 
collaborators showed that TAF7LKO mice have decreased brown 
fat tissue and increased muscle mass. These effects are associated 
with upregulation of genes involved in skeletal muscle develop-
ment and function, and a decrease in brown fat gene expression 
programs. Gain- and loss-of-TAF7L-function studies performed 
in cell lines, such as 10T1/2 and C2C12, further demonstrated 
that TAF7L modulates mesenchymal cells fate. To determine the 
mechanisms through which TAFL4 may tip the balance toward 
the brown adipose lineage, the authors performed immune-pre-
cipitation studies and identified a fat-specific complex containing 
only a subset of canonical TFIID-TAF subunits co-purifying with 
TAF and PPARγ. These TAF7L-containing TFIID complexes 
appear to mediate DNA looping between distal enhancers and 
core promoter elements in adipose tissues, suggesting that TAF7L 
is a tissue-specific subunit of TFIID involved in the coordination 
of long-range chromatin interactions to specify brown fat line-
age. These studies suggest the possibility of the existence of novel 
additional fat depot-selective TFIID complexes each involved in 
the determination of a distinct fat cell type.
Zfp516
In search for novel regulators of thermogenic tissue function, 
Dempersmier and colleagues in the group of Hei Sook Sul per-
formed a high-throughput screen of factors binding to the UCP1 
promoter. Through this analysis, it was shown that the Kruppel-
like zinc finger protein Zfp516 directly binds to a proximal region 
of the UCP1 promoter present at −70 to −45 bp from the start 
site (30). More detailed molecular analysis revealed that Zfp516 
is induced upon cold exposure and that it regulates UCP1 gene 
expression in complex with the coactivator PRDM16. Analysis 
of promoter sequences upstream of a number of brown fat genes 
revealed the presence of sequence similarities with the CCACT 
DNA stretch identified in the UCP1 promoter, and bound by 
Zfp516, and ChiP studies confirmed the ability of Zfp516 to 
occupy a similar motif also in the promoter of PGC1α and Cox8b. 
Analysis of inguinal fat depots of mice with overexpression of 
Zfp516 driven by the −5.4 aP2 promoter kept at room tempera-
tures showed increased clusters of cells containing multilocular 
lipid droplets, elevated UCP1 staining, consistent with increased 
amounts of beige fat cells. Furthermore, it was shown that these 
mutant mice have higher oxygen consumption levels. Assessment 
of the specific tissues contributing to increased respiratory activ-
ity in mice overexpressing Zfp516 revealed a selective effect of 
Zfp516 in inguinal fat, while no changes in respiration were 
observed in brown fat tissue. Consistent with the effects resulting 
from increased number of beige fat cells in iWAT, Zfp516 trans-
genic mice showed elevation in their core basal temperatures, had 
improved cold tolerance, and were protected from diet induced 
obesity. Global ablation of Zfp516, although lethal, allowed the 
analysis of the effects of ablation of Zfp516 on the early develop-
mental phases of brown fat formation. Embryos lacking Zfp516 at 
day 20.5 showed reduced brown fat mass and decreased brown fat 
gene expression in presumptive BAT. Overall, the data obtained 
in the two genetic models described highlight a dual role for 
Zfp516 in controlling the development of brown tissue and also 
in the modulation of beige fat cells function in adult mice.
P107
To characterize novel transcriptional regulators involved in the 
commitment of stem cells toward the adipocyte lineage, Scimè 
and colleagues (31) investigated the role of the Rb family member 
p107, previously shown to modulate white adipocyte differentia-
tion through its repression of PGC1α (32). The expression of p107 
appeared to be tightly controlled given that it was found to be 
expressed selectively in white fat stem cells but completely absent 
from those giving rise to brown fat. Loss-of-function studies 
demonstrated that p107 ablation is permissive for the formation 
of brown fat adipocytes and required for PRDM16-mediated 
brown fat programing of mesenchymal stem cells. Additional 
studies will determine the specific mechanisms through which 
this transcriptional corepressor ultimately influences brown 
versus white fate choices.
ewing Sarcoma
The group of Sean Lee recently demonstrated an unexpected, 
novel role for the Ewing Sarcoma (EWS) factor in brown fat 
biology (33). Park and colleagues showed that in the absence 
of EWS, pups die within 24 h after their birth and that the only 
pathological abnormality they manifest is a marked reduction in 
brown fat tissue. Histological analysis of the presumptive BAT 
present in these embryos revealed reduced UCP1 staining, loss 
of the characteristic multilocular lipid droplet phenotype and 
molecular studies demonstrated decreased levels of factors such 
as PGC1α and PRDM16. Analysis of brown adipocyte differen-
tiation in immortalized preadipocytes generated from EWS WT 
and null newborn pups showed that EWS null cells are unable 
to differentiate when treated with a differentiation-inducing 
cocktail. To gain further clues to mechanistically define how EWS 
affects differentiation, the authors studied the patterns of gene 
expression in WT and EWS null cells and observed that EWS 
deficiency affected the mRNA levels of the gene encoding for 
the bone morphogenic protein 7 (BMP7), as well as for CEBPβ 
during the initial stages of differentiation. Specific analysis of the 
effects of EWS on the expression of this cell fate determination 
factor revealed that EWS occupies the BMP7 promoter when 
in a complex with YBX1, a multifunctional protein involved in 
both transcription and translation. Complementation studies 
employing exogenous BMP7 restored differentiation in EWS null 
cells demonstrating that lack of BMP7 constituted their differen-
tiation block. To assess whether lack of EWS would affect beige 
cells function, the authors studied EWS heterozygous mice and 
showed that they have significantly reduced beige gene activation 
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in response to rosiglitazone and β-adrenergic stimulation. These 
studies demonstrate novel tissue-specific functions of EWS as a 
brown fat determination factor through the control of the early 
cell fate steps involving the activation of BMP7 and suggest a 
possible role in EWS in the activation of beige cells in response 
to pharmacological treatment. Studies of fat tissue conditional 
animal models will permit the assessment of the contribution of 
EWS on mature brown fat functionality.
Foxa3
To specifically identify novel transcriptional regulators involved 
in early events regulating fat differentiation, Xu and colleagues 
performed a genetic screen using a si-RNA library and assessed 
the effects of knocking down the expression of each forkhead 
protein on adipogenesis (34). This systematic analysis led to 
the demonstration that the winged helix factor Foxa3 is a novel 
modulator of adipocyte differentiation and of its function. 
Analysis of WT and Foxa3 null mice revealed that the absence of 
Foxa3 in vivo can decrease the expansion of the visceral adipose 
tissue compartment in response to HFD but does not reduce 
the enlargement of the subcutaneous fat tissue. This depot-
selective protection from the development of intra-abdominal 
obesity during high-fat diet regimens (34) was associated with 
improved insulin sensitivity. Analysis of the long-term effects of 
Foxa3 deficiency on late onset metabolic dysfunction revealed 
that mice lacking Foxa3 kept on a normal chow diet for more 
than a year have increased browning of subcutaneous tissue, 
as indicated by increased UCP1 staining in iWAT and elevated 
expression of a number of classic thermogenic and lipid oxidation 
genes in addition to beige specific markers such as Tbx1. These 
morphological and gene expression changes in iWAT, consistent 
with the acquisition of a beige phenotype, were associated with 
increased oxygen consumption (35). Analysis of Foxa3’s mode 
of action indicated that Foxa3 controls calorie hoarding through 
the upregulation of PPARγ levels via transcriptional cooperation 
with CEBPs, as revealed by coimmunoprecipitation and ChIP 
studies demonstrating that CEBPs interact with Foxa3 at the 
PPARγ promoter. In addition, Foxa3 suppresses thermogenesis 
in BAT and iWAT through interference with CREB-mediated 
induction of PGC1α expression. Analysis of the changes in 
Foxa3 mRNA levels in response to HFD and during the course 
of aging revealed that Foxa3 is fat depot-selectively induced in 
response to nutritional and developmental cues. Specifically, 
while diets rich in fat lead to increased Foxa3 mRNA levels only 
in the visceral fat depot, and not in subcutaneous adipose tis-
sue, the aging process is associated with increased Foxa3 levels 
most prominently in subcutaneous fat and in BAT. Given the 
role that other Foxa family members have been shown to play as 
pioneering factors on chromatin remodeling (36), it is plausible 
that Foxa3 may exert its calorie hoarding function through a 
number of other mechanisms in addition to those involving the 
control of PPARγ and PGC1α and their downstream programs. 
Ongoing studies in the laboratory are characterizing novel 
Foxa3’s gene targets in distinct fat subtypes and unraveling the 
signals regulating the unique pattern of expression of Foxa3 in 
selected depots.
HSF1
To identify novel modulators of fat tissue browning, Ma and 
colleagues used PGC1α expression as a read-out and performed 
an in  silico screen of possible functional binding sites located 
upstream of the PGC1α promoter (37). This analysis led to the 
identification of a putative heat shock motif (HSE) and studies 
involving overexpression of HSF1, or HSF1 activation via its 
agonists, in isolated cells and in  vivo, demonstrated that HSF1 
induces PGC1α and that it can turn on a cascade of mitochon-
drial PGC1α-dependent gene programs. ChIP assays revealed 
that upon cold exposure, HSF1 occupies the heat shock ele-
ment present in the PGC1α promoter in both BAT and iWAT, 
and coimmunoprecipitation studies demonstrated that HSF1 
physically interacts and functionally cooperates with PGC1α in a 
feed-forward regulatory loop on the PGC1α promoter. Given the 
in vitro evidence of HSF1 involvement in PGC1α activation, it 
was hypothesized that absence of HSF1 in vivo would bring about 
abnormal metabolic functions. Analysis of the effects of ablation 
of HSF1 on a number of parameters demonstrated that HSF1 
KO mice are more sensitive to low temperatures. Furthermore, 
morphological and molecular analysis of adipose tissues of 
WT and HSF1 KO mice revealed increased lipid deposition in 
BAT and iWAT of mice lacking HSF1, reduced UCP1 staining, 
decreased UCP1 protein levels in inguinal fat tissues, and reduced 
thermogenic and β-oxidation expression programs, indicating 
overall reduced brown and beige tissues functionality. Genetic 
experiments involving gain-of-HSF1-function selectively in 
iWAT and in muscle enabled through adenoviral-mediated 
expression of HSF1 provided further confirmatory evidence that 
HSF1 increases mitochondrial and thermogenic gene programs 
and leads to elevation in energy consumption. Analysis of the 
consequences of pharmacological activation of HSF1 during 
high-fat diet via celastrol, a natural HSF1 agonist present in 
herbal extracts used in Chinese medicine, revealed enhanced 
subcutaneous fat browning, increased thermogenesis and energy 
consumption, and reduced adipose tissue expansion, providing 
a proof of concept that HSF1 may represent a possible target in 
obesity prevention. Of note, it has been recently reported that 
celastrol is also efficacious in inducing weight loss in obese mice 
through a mechanisms involving appetite suppression via leptin 
sensitization (38). Although it appears that celastrol prevents 
and treats obesity through distinct pathways, the evidence that 
obese mice treated with celastrol lose weight even when their 
food intake is equalized to that of controls suggest that celastrol 
may activate the HSF1 pathway and increase energy expenditure 
also in obese states. Ongoing studies are dissecting genetically the 
contribution of distinct organs to HSF1-mediated modulation of 
energy expenditure and discriminating between HSF1 effects on 
central regulatory signals and those on peripheral organs.
KLF11
Loft and colleagues in the Mandrup laboratory have recently 
demonstrated a novel role for the Kruppel-like factor, KLF11, 
in the control of browning of human adipocytes (39). KLF11, 
also known as Mody 1, had been previously shown to regulate 
pancreatic β-cell function and variants of this gene have been 
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shown to be associated with diabetes. The Mandrup group has 
now provided novel evidence that KLF11 is highly expressed in 
beige cells and that it is a direct target of agonist liganded PPARγ. 
This factor induces reprograming of beige cells in response to 
TZDs through functional cooperation with PPARγ and selective 
activation of brown fat super-enhancers, suggesting a novel role 
for KLF11 in the stabilization of the expression of beige gene 
targets in human cells.
iRF4
Kong and colleagues in the Rosen group recently characterized 
the interferon regulatory factor 4 (IRF4) as a transcriptional regu-
lator of adaptive thermogenesis (40). IRF4 had been previously 
studied in the context of white adipocytes and shown to have an 
anti-lipogenic activity through the control of genes such as adi-
pocyte triglyceride lipase and hormone-sensitive lipase (41). In 
the new analysis, Kong and colleagues show that IRF4 is induced 
by cold exposure in brown fat cells. This pattern of expression 
prompted the assessment of the function of IRF4 also in BAT, 
in addition to that previously described in white fat. Analysis of 
brown fat-specific IRF4 transgenic mice demonstrated that IRF4 
is sufficient to increase energy expenditure and to protect from 
diet-induced obesity. IRF4 overexpressing mice show smaller 
brown fat size, reduced lipid stores, and increased expression of 
a selected number of genes involved in thermogenesis. Of note, 
IRF4 overexpression induced browning in epididymal WAT but 
not in iWAT. Conversely, selective ablation of IRF4 driven by the 
UCP1 promoter was associated with reduced energy expendi-
ture, increased predisposition to diet induced obesity and cold 
intolerance. Interestingly, in contrast to the selective “beigeing” 
effects in epididymal WAT of IRF4 overexpressing mice, UCP1 
promoter-driven ablation of IRF4 reduced beige cells in iWAT of 
mice chronically exposed to low temperatures. Mechanistically, 
IRF4 cooperates with PGC1α, via reciprocal gene expression 
regulation, direct protein–protein interaction and transcriptional 
cooperation in the induction of thermogenic genes. These data 
suggest that IRF4 coordinates heat generation by modulating 
lipolysis in white fat and thermogenic gene expression programs 
in brown and beige fat depots.
Zic 1
It has been recently suggested that Zic 1, a member of a family of 
zinc finger factors of the cerebellum previously involved in a vari-
ety of developmental processes, may also play a role in brown fat 
development and function. Zic 1 involvement in BAT biology was 
initially suggested when it was identified as one of the top genes 
differentially expressed in brown fat in comparison to white fat 
(22). A number of studies have now provided evidence that Zic 1 
expression is restricted to brown fat cells, even in undifferentiated 
states, and that its levels are independent of changes in tempera-
tures and dietary states, proposing Zic 1 as a selective marker of 
brown adipose tissue. In vitro analyses have only recently started 
to address the function of this transcriptional regulator. Studies 
performed by Nedergaard’s group have demonstrated that Zic 
1 downregulation via knockdown is associated with blunted 
UCP1 induction in response to norepinephrine stimulation 
(42). Additional functional and physiological studies possibly 
involving genetic mouse models with conditional modulation of 
Zic 1 levels in brown fat will define more precisely whether Zic 1 
is strictly required for BAT development or for its functionality 
in adulthood or for both.
Zbtb16
To identify novel regulators of adaptive thermogenesis, Plaisier 
and colleagues analyzed transcriptomes coordinately regulated 
upon cold exposure in both BAT and muscle and identified 
Zbtb16 among the most robustly expressed genes in these condi-
tions (43). Zbtb16 (also called PLZF) had previously emerged 
from a genome-wide screen of genes modulating adipocyte 
differentiation (44) and shown to suppress differentiation in L1 
cells; however, no studies linked Zbtb16 to BAT function. In the 
studies by Plaisier and colleagues, overexpression of Zbtb16 was 
associated with increased expression of brown fat makers, such 
as UCP1, PGC1α, PPARα, and mitochondrial and β-oxidation 
genes. Detailed analysis of mitochondrial energetics revealed 
increased respiration in cells, such as primary adipocytes and 
C2C12 myoblasts, with overexpression of Zbtb16 and showed 
increased mitochondrial biogenesis. Survey of the expression 
of Zbtb16 in tissues such as white fat and heart of 100 different 
mouse strains indicated that Zbtb16 levels inversely correlate 
to metabolic traits, such as increased body weight and fat mass. 
The generation and the detailed characterization of conditional 
genetic models of this factor will aid in the definition of the physi-
ological function of Zbtb16 in brown and/or beige fat physiology.
THeRMOGeNeSiS AND AGiNG
It has been reported that the aging process is associated with a 
selective expansion and redistribution of white fat stores specifi-
cally in the visceral compartment and with progressive metabolic 
decline (45). Evidence indicates that not only the amount of 
thermogenic fat tissues decreases during the aging process due 
to apoptosis but that its thermogenic functionality is reduced in 
old animals and in aged humans due, at least in part, to decreased 
sensitivity to β-adrenergic stimulation (46). Specifically in mice, 
it has been observed that as they approach mid age, their brown 
adipose tissue gradually involutes. It has been hypothesized 
that the progressive atrophy observed may be endogenously 
controlled and determined by the decrease in gonadal hormones, 
known to support the viability and functionality of BAT in matu-
rity, and by the tight negative control exerted by cortisol (46). 
Given the impact of brown fat and beige cells on energy balance, 
preservation, and/or restoration of functional brown and beige 
tissues may be an attractive strategy to protect from obesity and 
metabolic disorders that arise at an old age (47); however, to date, 
the main transcriptional switches that slow down, or accelerate, 
the involution of this tissue during late life stages have not been 
identified. Although the majority of the factors reviewed here 
have been shown to affect either the development of thermogenic 
tissues or their function in adult mice, only a few of them have 
been fully characterized in mid age or older mice. Specifically, it 
has been analyzed the long-term impact of the ablation PRDM16 
specifically in the brown adipose lineage (Myf5-ΔPRDM16) (26). 
These studies revealed that 11-month-old Myf-ΔPRDM16 KO 
PRDM3
TAF7L
EWS
Zfp516
PRDM16 Foxa3
PRDM16
PGC1α
IRF4
HSF1
Atrophy
Involuon
Lipid Storage
Mullocularity
Thermogenic Funcon
UCP1
FiGURe 1 | This illustration depicts the transcriptional regulators that have been shown to modulate in vivo brown fat tissue during organogenesis, 
maturation, and involution. The blue triangle indicates the progressive loss of multilocular lipid content, thermogenic function, and UCP1 levels during aging, while 
the yellow one indicates the increased whitening of BAT, composed of cells containing large lipid deposits, and atrophy observed in old mice.
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mice have increased whitening of brown fat tissue and reduced 
oxygen consumption levels; however, despite their decreased 
energy output and dysfunctional BAT, they do not show increased 
predisposition to obesity compared to age-matched WT controls. 
It remains to be determined whether the absence of an obese 
phenotype in these mice is animal model-dependent or whether 
compensatory mechanisms counteract the accretion of white fat 
stores in these mice. Indeed, given that PRDM3 offsets the effects 
of PRDM16 ablation during early development, it is conceivable 
that other factors, or other PRDM family members, may partly 
complement and compensate for the loss of PRDM16 late in life. 
Alternatively, it is possible that obesity would become evident 
only at later stages in life due to small, cumulative effects on fat 
stores. Nonetheless, metabolic studies of Myf-ΔPRDM16 mice 
older than 1 year or of old PRDM16 fat KO mice with impov-
erished beige cell contingent and measurement of longevity in 
diverse PRDM16 KO and transgenic mice will better define the 
role of PRDM16 in age-associated metabolic dysfunction and 
lifespan extension.
Analysis of the metabolic profiles of WT and Foxa3 null mice have 
provided supportive evidence that increasing beige fat cells in aging 
may be beneficial in preventing metabolic dysfunction and even 
extending life. In vivo ablation of Foxa3 was shown to be associated 
with a lean phenotype, increased energy expenditure, and improved 
insulin sensitivity in mice older than 1 year fed a normal chow diet 
(35). The metabolic beneficial effects of Foxa3 ablation appeared to be 
associated with increased browning of iWAT in 14-month-old mice. 
In addition, it was observed that ablation of Foxa3 positively impacted 
longevity contributing to lifespan extension. Analysis of gene expres-
sion revealed that Foxa3 levels are robustly upregulated selectively 
in inguinal and brown fat depots in 14-month-old mice compared 
to levels observed in young 2-month-old mice. Overall, the analysis 
of the consequences of Foxa3 ablation in late life stages suggests that 
Foxa3 may constitute a potential target to counteract aging and its 
associated metabolic pathologies (Figure 1). These studies support 
the idea that systematic metabolic profiling of knockout or transgenic 
mice with altered expression of transcriptional regulators of brown 
and beige fat during the aging process will permit a more detailed 
mechanistic understanding of the impact of thermogenic tissues on 
metabolic disorders that occur late in life.
It has been demonstrated that brown and beige thermogenic 
cells increase energy expenditure and suggested that turning 
on these cells to boost consumption may represent a successful 
approach to combat the rampant obesity epidemic (8, 15). As we 
improve our understanding of the key molecular switches that 
can modulate thermogenesis, a number of questions remain to be 
answered to fully exploit the therapeutic potential of these cells 
in counteracting metabolic dysfunction at different life stages. 
For example, it needs to be clarified how changes in hormonal 
signals occurring during the aging process can contribute to the 
progressive involution of brown fat tissue. Given some of the 
reports suggesting that cortisol levels increase during aging (48), 
assessing how steroid hormones may regulate the expression of 
thermogenic effectors late in life could provide clues on some of 
the mechanisms through which endogenous signals unable or 
disable the functionality of brown and beige cells. Furthermore, 
the generation of new animal models to allow the modulation 
of the expression of specific transcriptional regulators in a 
spatiotemporal-restricted manner  –  fat depot-selectively at an 
old age – will be beneficial in determining which thermogenic 
factors may be targeted to prevent the functional decay of brown 
and beige fat cells shown to occur during the aging process.
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